WHW Weekly Scoop #65

🙋‍♀️ $500M acquisition, 1,800+ retail launches, and a pink urinal revolution
Written by
WHW Team
Published on
September 8, 2025

💊 Remedy Meds Acquires Thirty Madison in $500M+ All-Stock Deal

The transaction creates a multi-brand platform combining Remedy Meds, Keeps, Nurx, and Cove.

"By bringing together Thirty Madison's trusted brands with Remedy Med's acquisition engine, retention system, and pharmacy infrastructure, we will broaden access, shorten time-to-treatment, and maintain the financial discipline that has defined our growth,"

- Haris Memon, Founder & CEO, Remedy Meds

🔗 Read More

💰 Shoppers Foundation Commits $1.75M to 27 Women's Health Organisations

The Community Grants Programme addresses critical gaps in healthcare for women across Canada.

🔗 Read More

🧬 Femasys Closes $8M Financing for Product Commercialisation

The funding will support commercialisation of FemaSeed fertility treatment and FemBloc non-surgical birth control.

"Ramping commercialisation of our FemaSeed and FemBloc offerings remains our highest priority, and this financing enables us to execute on our strategy, achieve near-term milestones, strengthen our market presence, and accelerate toward meaningful revenue growth,"

- Kathy Lee-Sepsick, CEO & Founder, Femasys

🔗 Read More

🔬 Salient Bio Raises £2.35M for Women's Health Microbiome Diagnostics

The London-based startup will expand its SIGNAL platform for faster diagnostics affecting women.

🔗 Read More

🛒 Bonafide Health Launches Exclusively at 1,800+ Target Stores Nationwide

The menopause company brings hormone-free, clinically researched solutions to retail for the first time.

🔗 Read More

⌚ Zepp Health Acquires Wild.AI to Expand Female Athlete Support

The acquisition includes Wild.AI's hormone-informed coaching technology to help women optimise performance across life stages.

🔗 Read More

🚽 Denmark's Lapee Secures €800K for Pink Urinals Revolution

The viral sanitation startup launches equity crowdfunding to expand its gender-inclusive public facilities globally.

🔗 Read More

🔬 Spark Biomedical Launches OhmBody™ Menstrual Wellness Device

The non-invasive wearable aims to reduce cramps and menstrual blood loss without hormones or surgery.

🔗 Read More

Another big week! Let us know what you're working on, or who we should feature next.  

Email us at info@womenshealthweek.com and put "Scoop Request" as the subject!

see more articles

WHW Weekly Scoop #67

✨ $100M in research, $55M Series C, and AI continues to drive investment

arrow icon

BoobyBiome Secures £2.5M To Advance Infant Health

arrow icon